| mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.002 |
1 |
| mRNA |
TG-101348 |
CTRPv2 |
pan-cancer |
AAC |
-0.002 |
1 |
| mRNA |
oligomycin a |
CTRPv2 |
pan-cancer |
AAC |
0.002 |
1 |
| mRNA |
MS-275 |
gCSI |
pan-cancer |
AAC |
0.0031 |
1 |
| mRNA |
L-685458 |
CCLE |
pan-cancer |
AAC |
-0.0025 |
1 |
| mRNA |
valdecoxib |
CTRPv2 |
pan-cancer |
AAC |
-0.0016 |
1 |
| mRNA |
KIN001-260 |
GDSC1000 |
pan-cancer |
AAC |
-0.0014 |
1 |
| mRNA |
Cisplatin |
GDSC1000 |
pan-cancer |
AAC |
-0.0016 |
1 |
| mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0016 |
1 |
| mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
0.0012 |
1 |